[Skip to Content]
[Skip to Content Landing]
Citations 0
October 4, 2000

Issues in Establishing Primary Stroke Centers

Author Affiliations

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Executive Deputy EditorIndividualAuthor

JAMA. 2000;284(13):1647. doi:10.1001/jama.284.13.1647

To the Editor: Part of the rationale for primary stroke centers, which Dr Alberts and colleagues1 endorse, is to rapidly administer tPA to patients experiencing strokes. Alberts discloses that he has financial ties to Genentech Inc, which manufactures tPA.

It would be reassuring if the authors could definitively state that they have no other financial ties to any manufacturer of tPA. It would also be important to state that no expenses of the Brain Attack Coalition have been underwritten by any manufacturer of tPA.